Brain Advance Access originally published online on March 17, 2005
Brain 2005 128(5):1093-1101; doi:10.1093/brain/awh451
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study
1 INSERM (Institut National de la Santé et de la Recherche Médicale) Unit 593, 2 INSERM E0338 and 3 Department of Neurology, University Hospital of Bordeaux, France
Correspondence to: Hélène Amieva, INSERM U.593, Université Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux cedex, France E-mail: helene.amieva{at}isped.u-bordeaux2.fr
Better knowledge of the preclinical phase of Alzheimer's disease would be an important advance to allow earlier treatment of this ominous disease. This prodromal period was investigated in the Paquid cohort by analysing change in cognitive performances at five time points over a 9 year period. Neuropsychological measures including global cognitive functioning (Mini-Mental State Examination), visuo-spatial memory (Benton Visual Retention Test), verbal fluency (Isaacs Set Test) and abstract thinking (Wechsler Similarities Test) were assessed in 215 future Alzheimer's disease subjects and 1050 individuals without dementia. The results showed that cognitive performances of the pre-morbid subjects at baseline were already lower than those of individuals without dementia (1.4 points less on the Mini-Mental State Examination; 1.8 points less on the Benton Visual Retention Test; 4 points less on the Isaacs Set Test and 0.8 points less on the Wechsler Similarities Test). For some neuropsychological tests, an acceleration of the decline occurred
3 years before the diagnosis and, for each test, the course of decline was modulated by education level. These findings show that abnormally low performances can be evidenced 9 years before the clinical diagnosis of Alzheimer's disease in several domains of cognition beyond memory and that cognitive change over time can be influenced by education.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Linazasoro, C. C. Rowe, V. L. Villemagne, and C. L. Masters IMAGING {beta}-AMYLOID BURDEN IN AGING AND DEMENTIA Neurology, April 29, 2008; 70(18): 1649 - 1650. [Full Text] [PDF] |
||||
![]() |
A. F. Fotenos, M. A. Mintun, A. Z. Snyder, J. C. Morris, and R. L. Buckner Brain Volume Decline in Aging: Evidence for a Relation Between Socioeconomic Status, Preclinical Alzheimer Disease, and Reserve Arch Neurol, January 1, 2008; 65(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Dickerson, R. A. Sperling, B. T. Hyman, M. S. Albert, and D. Blacker Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment Arch Gen Psychiatry, December 1, 2007; 64(12): 1443 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sarazin, C. Berr, J. De Rotrou, C. Fabrigoule, F. Pasquier, S. Legrain, B. Michel, M. Puel, M. Volteau, J. Touchon, et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study Neurology, November 6, 2007; 69(19): 1859 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Goodenowe, L. L. Cook, J. Liu, Y. Lu, D. A. Jayasinghe, P. W. K. Ahiahonu, D. Heath, Y. Yamazaki, J. Flax, K. F. Krenitsky, et al. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia J. Lipid Res., November 1, 2007; 48(11): 2485 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss, P. Maruff, C. A. Mathis, W. E. Klunk, C. L. Masters, and C. C. Rowe {beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Brain, November 1, 2007; 130(11): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kang, N. Cook, J. Manson, J. E Buring, and F. Grodstein Low dose aspirin and cognitive function in the women's health study cognitive cohort BMJ, May 12, 2007; 334(7601): 987 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Ingles, D. C. Boulton, J. D. Fisk, and K. Rockwood Preclinical Vascular Cognitive Impairment and Alzheimer Disease: Neuropsychological Test Performance 5 Years Before Diagnosis Stroke, April 1, 2007; 38(4): 1148 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seidler, P. Geller, A. Nienhaus, T. Bernhardt, I. Ruppe, S. Eggert, M. Hietanen, T. Kauppinen, and L. Frolich Occupational exposure to low frequency magnetic fields and dementia: a case-control study Occup. Environ. Med., February 1, 2007; 64(2): 108 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Proust-Lima, H. Amieva, J.-F. Dartigues, and H. Jacqmin-Gadda Sensitivity of Four Psychometric Tests to Measure Cognitive Changes in Brain Aging-Population-based Studies Am. J. Epidemiol., February 1, 2007; 165(3): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Saykin, H. A. Wishart, L. A. Rabin, R. B. Santulli, L. A. Flashman, J. D. West, T. L. McHugh, and A. C. Mamourian Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology, September 12, 2006; 67(5): 834 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Elkins, W. T. Longstreth Jr, T. A. Manolio, A. B. Newman, R. A. Bhadelia, and S. C. Johnston Education and the cognitive decline associated with MRI-defined brain infarct Neurology, August 8, 2006; 67(3): 435 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Boyle, R. S. Wilson, N. T. Aggarwal, Y. Tang, and D. A. Bennett Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline Neurology, August 8, 2006; 67(3): 441 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galimberti, N. Schoonenboom, P. Scheltens, C. Fenoglio, F. Bouwman, E. Venturelli, I. Guidi, M. A. Blankenstein, N. Bresolin, and E. Scarpini Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol, April 1, 2006; 63(4): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Scarmeas, S M Albert, J J Manly, and Y Stern Education and rates of cognitive decline in incident Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 308 - 316. [Abstract] [Full Text] [PDF] |
||||









